Literature DB >> 34678197

Implementation of non-communicable disease policies from 2015 to 2020: a geopolitical analysis of 194 countries.

Luke N Allen1, Simon Wigley2, Hampus Holmer3.   

Abstract

BACKGROUND: Non-communicable diseases (NCDs) are the leading cause of morbidity and mortality globally. We aimed to analyse trends in implementation of WHO-recommended population-level policies and associations with national geopolitical characteristics.
METHODS: We calculated cross-sectional NCD policy implementation scores for all 194 WHO member states from the 2015, 2017, and 2020 WHO progress monitor reports, and examined changes over time as well as average implementation by geographical and geopolitical region and income level. We developed a framework of indicators of national characteristics hypothesised to influence policy implementation, including democracy, corporate permeation (an indicator of corporate influence), NCD burden, and risk factor prevalence. We used multivariate regression models to test our hypotheses.
FINDINGS: On average, countries had fully implemented a third (32·8%, SD 18·2) of the 19 policies in 2020. Using aggregate policy scores, which include partially implemented policies, mean implementation had increased from 39·0% (SD 19·3) in 2015 to 45·9% (19·2) in 2017 and 47·0% (19·8) in 2020. Implementation was lowest for policies relating to alcohol, tobacco, and unhealthy foods, and had reversed for a third of all policies. Low-income and less democratic countries had the lowest policy implementation. Our model explained 64·8% of variance in implementation scores. For every unit increase in corporate permeation, implementation decreased by 5·0% (95% CI -8·0 to -1·9, p=0·0017), and for every 1% increase in NCD mortality burden, implementation increased by 0·9% (0·2 to 1·6, p=0·014). Democracy was positively associated with policy implementation, but only in countries with low corporate permeation.
INTERPRETATION: Implementation of NCD policies is uneven, but broadly improving over time. Urgent action is needed to boost implementation of policies targeting corporate vectors of NCDs, and to support countries facing high corporate permeation. FUNDING: The National Institutes for Health Research, the Swedish Research Council, the Fulbright Commission, and the Swedish Society of Medicine.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34678197     DOI: 10.1016/S2214-109X(21)00359-4

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN: 2214-109X            Impact factor:   26.763


  9 in total

1.  Embedding the Community and Individuals in Disease Prevention.

Authors:  Martine M Bellanger; Ke Zhou; Sophie A Lelièvre
Journal:  Front Med (Lausanne)       Date:  2022-04-04

2.  Unleashing implementation research to accelerate national noncommunicable disease responses.

Authors:  Tea Collins; Svetlana Akselrod; Daria Berlina; Luke N Allen
Journal:  Global Health       Date:  2022-01-24       Impact factor: 4.185

3.  The WHO FCTC's lessons for addressing the commercial determinants of health.

Authors:  Juliette McHardy
Journal:  Health Promot Int       Date:  2021-12-13       Impact factor: 2.483

Review 4.  Initiatives Addressing Precarious Employment and Its Effects on Workers' Health and Well-Being: A Systematic Review.

Authors:  Virginia Gunn; Bertina Kreshpaj; Nuria Matilla-Santander; Emilia F Vignola; David H Wegman; Christer Hogstedt; Emily Q Ahonen; Theo Bodin; Cecilia Orellana; Sherry Baron; Carles Muntaner; Patricia O'Campo; Maria Albin; Carin Håkansta
Journal:  Int J Environ Res Public Health       Date:  2022-02-16       Impact factor: 3.390

5.  Implementation research on noncommunicable disease prevention and control interventions in low- and middle-income countries: A systematic review.

Authors:  Celestin Hategeka; Prince Adu; Allissa Desloge; Robert Marten; Ruitai Shao; Maoyi Tian; Ting Wei; Margaret E Kruk
Journal:  PLoS Med       Date:  2022-07-25       Impact factor: 11.613

6.  Intelligent Identification of Early Esophageal Cancer by Band-Selective Hyperspectral Imaging.

Authors:  Tsung-Jung Tsai; Arvind Mukundan; Yu-Sheng Chi; Yu-Ming Tsao; Yao-Kuang Wang; Tsung-Hsien Chen; I-Chen Wu; Chien-Wei Huang; Hsiang-Chen Wang
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

7.  Study protocol: assessing the association between corporate financial influence and implementation of policies to tackle commercial determinants of non-communicable diseases: a cross-sectional analysis of 172 countries.

Authors:  Luke Nelson Allen; Simon Wigley; Hampus Holmer
Journal:  BMJ Open       Date:  2022-08-30       Impact factor: 3.006

8.  Conflict as a macrodeterminant of non-communicable diseases: the experience of Libya.

Authors:  Luke N Allen; Mohamed Aghilla; Mohini Kak; Giulia Loffreda; Cervantée Erice Koorey Wild; Arian Hatefi; Christopher H Herbst; Haider El Saeh
Journal:  BMJ Glob Health       Date:  2022-10

9.  Lessons Learnt from the EU Response to NCDs: A Content Analysis on Building Resilient Post-COVID Health Systems.

Authors:  Rana Orhan; Martina Paric; Katarzyna Czabanowska
Journal:  Healthcare (Basel)       Date:  2021-11-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.